KMC Speciality Hospitals (India) Limited
KMC Speciality Hospitals (India) Limited Fundamental Analysis
KMC Speciality Hospitals (India) Limited (KMCSHIL.BO) shows moderate financial fundamentals with a PE ratio of 39.21, profit margin of 12.88%, and ROE of 22.07%. The company generates $2.8B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 64.7/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze KMCSHIL.BO's fundamental strength across five key dimensions:
Efficiency Score
ExcellentKMCSHIL.BO demonstrates superior asset utilization.
Valuation Score
ModerateKMCSHIL.BO shows balanced valuation metrics.
Growth Score
ModerateKMCSHIL.BO shows steady but slowing expansion.
Financial Health Score
ExcellentKMCSHIL.BO maintains a strong and stable balance sheet.
Profitability Score
WeakKMCSHIL.BO struggles to sustain strong margins.
Key Financial Metrics
Is KMCSHIL.BO Expensive or Cheap?
P/E Ratio
KMCSHIL.BO trades at 39.21 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, KMCSHIL.BO's PEG of 1.92 indicates fair valuation.
Price to Book
The market values KMC Speciality Hospitals (India) Limited at 7.88 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 16.84 times EBITDA. This signals the market has high growth expectations.
How Well Does KMCSHIL.BO Make Money?
Net Profit Margin
For every $100 in sales, KMC Speciality Hospitals (India) Limited keeps $12.88 as profit after all expenses.
Operating Margin
Core operations generate 19.92 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $22.07 in profit for every $100 of shareholder equity.
ROA
KMC Speciality Hospitals (India) Limited generates $12.23 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
KMC Speciality Hospitals (India) Limited produces operating cash flow of $562.96M, showing steady but balanced cash generation.
Free Cash Flow
KMC Speciality Hospitals (India) Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
KMCSHIL.BO converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
39.21
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
1.92
vs 25 benchmark
P/B Ratio
Price to book value ratio
7.88
vs 25 benchmark
P/S Ratio
Price to sales ratio
5.04
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.47
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.36
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.22
vs 25 benchmark
ROA
Return on assets percentage
0.12
vs 25 benchmark
ROCE
Return on capital employed
0.22
vs 25 benchmark
How KMCSHIL.BO Stacks Against Its Sector Peers
| Metric | KMCSHIL.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 39.21 | 29.45 | Worse (Expensive) |
| ROE | 22.07% | 779.00% | Weak |
| Net Margin | 12.88% | -24936.00% (disorted) | Strong |
| Debt/Equity | 0.47 | 0.26 | Weak (High Leverage) |
| Current Ratio | 1.36 | 4.65 | Neutral |
| ROA | 12.23% | -19344.00% (disorted) | Strong |
KMCSHIL.BO outperforms its industry in 2 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews KMC Speciality Hospitals (India) Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation